Literature DB >> 30025558

Association between IgG N-glycans and Nonalcoholic Fatty Liver Disease in Han Chinese.

Zhong Yao Zhao1, Di Liu1, Wei Jie Cao1, Ming Sun1, Man Shu Song1, Wei Wang2, You Xin Wang2.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is a major public health issue worldwide. Immunoglobulin G (IgG) N-glycans are associated with risk factors for NAFLD, such as obesity and diabetes. A cross-sectional study involving 500 Han Chinese adults recruited from a community in Beijing was carried out to explore the association between IgG N-glycans and NAFLD. IgG N-glycosylation was significantly associated with NAFLD, with the disease showing a negative correlation with galactosylation (GP14, GP14n, and G2n), positive correlation with fucosylation (FBG2n/G2n), and positive correlation with bisecting N-acetylglucosamine (GlcNAc) [FBG2n/FG2n and FBG2n/(FG2n+FBG2n)], after controlling age, gender, and prevalence of obesity, type 2 diabetes mellitus, hypertension, and hyperlipidemia. In other words, the present study showed a possible association between NAFLD and the loss of galactose and elevations of fucose and bisecting GlcNAc. Aberrant IgG glycosylation might therefore be a potential biomarker for the primary or secondary prevention of NAFLD.
Copyright © 2018 The Editorial Board of Biomedical and Environmental Sciences. Published by China CDC. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30025558     DOI: 10.3967/bes2018.059

Source DB:  PubMed          Journal:  Biomed Environ Sci        ISSN: 0895-3988            Impact factor:   3.118


  5 in total

1.  The history of IgG glycosylation and where we are now.

Authors:  Brian A Cobb
Journal:  Glycobiology       Date:  2020-03-20       Impact factor: 4.313

2.  Immunoglobulin G Glycosylation Changes in Aging and Other Inflammatory Conditions.

Authors:  Fabio Dall'Olio; Nadia Malagolini
Journal:  Exp Suppl       Date:  2021

Review 3.  Nonalcoholic Fatty Liver Disease: Pathogenesis and Treatment in Traditional Chinese Medicine and Western Medicine.

Authors:  Tingting Shi; Li Wu; Wenjun Ma; Liping Ju; Minghui Bai; Xiaowei Chen; Shourong Liu; Xingxin Yang; Junping Shi
Journal:  Evid Based Complement Alternat Med       Date:  2020-01-04       Impact factor: 2.629

Review 4.  Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches.

Authors:  Eirini Martinou; Marinos Pericleous; Irena Stefanova; Vasha Kaur; Angeliki M Angelidi
Journal:  Diagnostics (Basel)       Date:  2022-02-04

5.  Ginkgo biloba Extract 50 (GBE50) Ameliorates Insulin Resistance, Hepatic Steatosis and Liver Injury in High Fat Diet-Fed Mice.

Authors:  Liu Li; Li Yang; Feng Yang; Xin-Lan Zhao; Shengjiang Xue; Fang-Hua Gong
Journal:  J Inflamm Res       Date:  2021-05-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.